Brief: Nanthealth Presented Clinical Data On Immunotherapy At The ASCO 2020 Virtual Scientific Program
18/06/2020 21:05
June 18 (Reuters) - NantHealth Inc NH.O :
* NANTHEALTH PRESENTED CLINICAL DATA ON IMMUNOTHERAPY,
MOLECULARLY
TARGETED AGENTS AND TUMOR BIOLOGY AT THE AMERICAN SOCIETY OF
CLINICAL ONCOLOGY (ASCO) 2020 VIRTUAL SCIENTIFIC PROGRAM
Source text for Eikon: ID:nBwfMT8Za
Further company coverage: NH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nanthealth
See all newsNantHealth plunges on Nasdaq share suspension notice
Brief: Nanthealth Inc On May 22 Received Notice From Nasdaq That Its Shares Will Be Suspended At Open Of Business On May 24
Brief: NantHealth Announces 1-For-15 Reverse Stock Split
NantHealth Inc reports results for the quarter ended in March - Earnings Summary
Brief: NantHealth Reports 2022 First Quarter Financial Results